ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 134 filers reported holding ZAI LAB LTD in Q2 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,635 | -15.2% | 58,965 | +1.8% | 0.01% | -15.4% |
| Q1 2023 | $1,927 | +32.1% | 57,949 | +22.0% | 0.01% | +18.2% |
| Q4 2022 | $1,459 | -100.0% | 47,510 | -46.6% | 0.01% | -50.0% |
| Q3 2022 | $3,043,000 | +13.4% | 88,967 | +15.0% | 0.02% | +22.2% |
| Q2 2022 | $2,683,000 | -37.1% | 77,371 | -20.2% | 0.02% | -18.2% |
| Q1 2022 | $4,265,000 | +13.4% | 96,971 | +62.1% | 0.02% | +29.4% |
| Q4 2021 | $3,760,000 | -61.3% | 59,831 | -35.1% | 0.02% | -67.3% |
| Q3 2021 | $9,721,000 | -19.7% | 92,234 | +34.8% | 0.05% | -22.4% |
| Q2 2021 | $12,108,000 | +49.9% | 68,411 | +13.0% | 0.07% | +48.9% |
| Q1 2021 | $8,080,000 | +791.8% | 60,553 | +455.9% | 0.04% | +650.0% |
| Q3 2020 | $906,000 | +40.2% | 10,893 | +38.5% | 0.01% | +20.0% |
| Q2 2020 | $646,000 | -21.0% | 7,867 | -50.5% | 0.01% | -44.4% |
| Q1 2020 | $818,000 | – | 15,882 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |